-
Infographic – U.S. Drug Prices vs. Other Countries
Rand Corporation published a study comparing U.S. drug prices to 32 other countries, and found U.S. residents pay on average 190 percent of the price paid elsewhere in the world.
-
Biotech Business Complex Slated for Colorado
A developer backed by a life science/real estate joint venture announced plans to create a new campus for biotechnology and related businesses in Boulder, Colorado.
-
Cannabinoid Synthesis Process Licensed to Spin-Off Company
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process.
-
AI Recreates Tumor Environment for Precision Cancer Care
A bioinformatics company designed an algorithm that digitally recreates the support network for tumors from RNA sequences, to guide precise treatments for cancer patients.
-
Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds
A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds.
-
Infant Gut Microbiome Biomarker Study Underway
A clinical study has begun analyzing infants’ stool samples to determine the characteristics of healthy microbial communities in young children.
-
Infographic – Tracking Global Monkeypox Spread
The data and chart show as of end of July, the highest concentrations of monkeypox cases per 1 million residents are in North America and Europe.
-
Univ. Labs Ink Licensing Deals for Covid-19 Tests
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections.
-
Immune Disease Biotech Acquired in $405M Deal
A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences.
-
Peptide Vaccine Shown to Reduce Harmful Cholesterol
Tests with lab monkeys show a vaccine with a synthetic peptide lowers so-called bad cholesterol in blood for longer periods than a comparable monoclonal antibody.